COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression
R Singh, SS Rathore, H Khan, S Karale… - Frontiers in …, 2022 - frontiersin.org
Background Obesity affects the course of critical illnesses. We aimed to estimate the
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients
A Sattler, E Schrezenmeier, UA Weber… - The Journal of …, 2021 - Am Soc Clin Investig
Novel mRNA-based vaccines have been proven to be powerful tools in combating the
global pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) …
global pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) …
COVID-19 and solid organ transplantation: a review article
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …
Early in the outbreak period, transplant societies recommended suspending living kidney …
[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
Interrelations between COVID-19 and other disorders
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …
COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature
Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …
COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current …
To date, four vaccines have been authorised for emergency use and under conditional
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …
Safety and immunogenicity of anti–SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants
O Marion, A Del Bello, F Abravanel… - Annals of internal …, 2021 - acpjournals.org
Background: Recipients of solid organ transplant (SOT) are a high-risk group for severe
SARS-CoV-2 infection. The mortality rate of patients with SOT during the COVID-19 …
SARS-CoV-2 infection. The mortality rate of patients with SOT during the COVID-19 …
Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients
All authors participated in conception or design of the work or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising it critically for important …
interpretation of data for the work; drafting the work or revising it critically for important …